CARROLS RESTAURANT GROUP, INC.

$ Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000080924824000061 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q2

Balance Sheet

Concept	2024 Q1	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$4.881M
YoY Change		-42.45%
Cash & Equivalents	$38.03M	$4.881M
Short-Term Investments
Other Short-Term Assets		$18.18M
YoY Change		27.62%
Inventory	$13.19M	$12.94M
Prepaid Expenses
Receivables		$24.52M
Other Receivables		$0.00
Total Short-Term Assets	$91.43M	$60.51M
YoY Change	33.91%	8.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$309.0M	$305.2M
YoY Change	-1.08%	-8.97%
Goodwill	$107.8M	$107.8M
YoY Change	0.0%	-13.42%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$9.160M	$12.25M
YoY Change	-36.17%	2.65%
Total Long-Term Assets	$1.481B	$1.524B
YoY Change	-3.8%	-5.39%
TOTAL ASSETS
Total Short-Term Assets	$91.43M	$60.51M
Total Long-Term Assets	$1.481B	$1.524B
Total Assets	$1.572B	$1.584B
YoY Change	-2.2%	-4.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$37.71M	$31.53M
YoY Change	23.69%	3.81%
Accrued Expenses		$96.98M
YoY Change		-3.64%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due	$7.108M	$7.368M
YoY Change	-3.17%	17.16%
Total Short-Term Liabilities	$192.4M	$173.5M
YoY Change	7.23%	4.22%
LONG-TERM LIABILITIES
Long-Term Debt	$420.3M	$465.7M
YoY Change	-12.6%	-4.29%
Other Long-Term Liabilities	$956.0K	$1.051M
YoY Change	-92.19%	-19.34%
Total Long-Term Liabilities	$421.3M	$466.8M
YoY Change	3341.17%	-4.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$192.4M	$173.5M
Total Long-Term Liabilities	$421.3M	$466.8M
Total Liabilities	$1.384B	$1.433B
YoY Change	-4.98%	-2.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.51M	-$136.1M
YoY Change	-27.35%	64.65%
Common Stock	$298.2M	$294.3M
YoY Change	1.7%	1.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$15.85M	$14.43M
YoY Change	12.19%	2.11%
Treasury Stock Shares
Shareholders Equity	$188.0M	$151.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.572B	$1.584B
YoY Change	-2.2%	-4.94%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q2

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000809248
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-33174
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	CARROLS RESTAURANT GROUP, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-3804854
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Syracuse,
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	13203
CY2024Q1	dei	City Area Code CityAreaCode	315
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	424-0513
CY2024Q1	dei	Trading Symbol TradingSymbol	TAST
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	52621276	shares
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	307526000	usd
CY2024Q1	tast	Franchise Rights Accumulated Amortization FranchiseRightsAccumulatedAmortization	178228000	usd
CY2023Q4	tast	Franchise Rights Accumulated Amortization FranchiseRightsAccumulatedAmortization	174745000	usd
CY2024Q1	tast	Finite Lived Franchise Rights Net FiniteLivedFranchiseRightsNet	295142000	usd
CY2023Q4	tast	Finite Lived Franchise Rights Net FiniteLivedFranchiseRightsNet	298626000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	107751000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	107751000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19975000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19299000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25414000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	26048000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	734510000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	743250000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9160000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9591000	usd
CY2024Q1	us-gaap	Assets Assets	1572362000	usd
CY2023Q4	us-gaap	Assets Assets	1592492000	usd
CY2024Q1	tast	Long Term Debt Currentand Finance Lease Liabilities LongTermDebtCurrentandFinanceLeaseLiabilities	7108000	usd
CY2023Q4	tast	Long Term Debt Currentand Finance Lease Liabilities LongTermDebtCurrentandFinanceLeaseLiabilities	7159000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	49631000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	49424000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	37713000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	37797000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	4323000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	8705000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	36984000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	63787000	usd
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	7188000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	8963000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	49426000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	29120000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	192373000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	204955000	usd
CY2024Q1	tast	Long Term Debt Noncurrentand Finance Lease Liabilities LongTermDebtNoncurrentandFinanceLeaseLiabilities	420346000	usd
CY2023Q4	tast	Long Term Debt Noncurrentand Finance Lease Liabilities LongTermDebtNoncurrentandFinanceLeaseLiabilities	421788000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	11311000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	1384322000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1407259000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	100	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	52479387	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51602340	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	549000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	539000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	297663000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	296972000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99508000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-103172000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5189000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5320000	usd
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	15853000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	14426000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	188040000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	185233000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1572362000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1592492000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	452192000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	445162000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3664000	usd
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $.01 per share
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38030000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44504000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	25033000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	22438000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	13189000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	15237000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15174000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17521000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	91426000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	99700000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	578488000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	570062000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	308959000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	750183000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	758115000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	10823000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	11090000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	10597000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57402169	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56738837	shares
CY2024Q1	tast	Franchise Agreement Term FranchiseAgreementTerm	P20Y
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	968 James Street
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	100	shares
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	118166000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	125443000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	150785000	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	146324000	usd
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	32025000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	31834000	usd
CY2024Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	74037000	usd
CY2023Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	69132000	usd
CY2024Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	18459000	usd
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	17898000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1989000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1097000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30826000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25740000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18512000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18718000	usd
CY2024Q1	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1356000	usd
CY2023Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1340000	usd
CY2024Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2041000	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1506000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	442125000	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	434923000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	10067000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	10239000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	6413000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	8233000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3654000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2006000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1142000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3664000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52325476	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51422010	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64221877	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61420034	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3664000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-131000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1137000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3533000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-273000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	185233000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1989000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2024Q1	tast	Repurchaseof Treasury Stock RepurchaseofTreasuryStock	1427000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	45000	usd
CY2024Q1	tast	Changein Valuationof Interest Rate Swap ChangeinValuationofInterestRateSwap	131000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	188040000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	150842000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1097000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2023Q2	tast	Repurchaseof Treasury Stock RepurchaseofTreasuryStock	295000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	260000	usd
CY2023Q2	tast	Changein Valuationof Interest Rate Swap ChangeinValuationofInterestRateSwap	1137000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	151371000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3664000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1429000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1521000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1989000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1097000	usd
CY2024Q1	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1356000	usd
CY2023Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1340000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18512000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18718000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	512000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	543000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	27000	usd
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	32000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	223000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1142000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	12071000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	14222000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12337000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7993000	usd
CY2024Q1	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	2582000	usd
CY2023Q2	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	858000	usd
CY2024Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	6461000	usd
CY2023Q2	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	2035000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	4289000	usd
CY2023Q2	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	3774000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	3058000	usd
CY2023Q2	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	1322000	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	16390000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	7989000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	1851000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	0	usd
CY2024Q1	tast	Properties Purchased For Sale Leaseback PropertiesPurchasedForSaleLeaseback	2573000	usd
CY2023Q2	tast	Properties Purchased For Sale Leaseback PropertiesPurchasedForSaleLeaseback	0	usd
CY2024Q1	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	1726000	usd
CY2023Q2	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	1126000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15386000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6863000	usd
CY2024Q1	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	1063000	usd
CY2023Q2	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	1063000	usd
CY2024Q1	tast	Borrowings Under Prior Revolving Credit Facility BorrowingsUnderPriorRevolvingCreditFacility	0	usd
CY2023Q2	tast	Borrowings Under Prior Revolving Credit Facility BorrowingsUnderPriorRevolvingCreditFacility	11000000	usd
CY2024Q1	tast	Repayments Under Prior Revolving Credit Facility RepaymentsUnderPriorRevolvingCreditFacility	0	usd
CY2023Q2	tast	Repayments Under Prior Revolving Credit Facility RepaymentsUnderPriorRevolvingCreditFacility	23500000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	935000	usd
CY2023Q2	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	755000	usd
CY2024Q1	tast	Purchase From Sale Of Treasury Stock PurchaseFromSaleOfTreasuryStock	1427000	usd
CY2023Q2	tast	Purchase From Sale Of Treasury Stock PurchaseFromSaleOfTreasuryStock	295000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3425000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14613000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6474000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13483000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44504000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18364000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38030000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4881000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	10184000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	12137000	usd
CY2024Q1	tast	Interest Paid On Lease Financing Obligations InterestPaidOnLeaseFinancingObligations	0	usd
CY2023Q2	tast	Interest Paid On Lease Financing Obligations InterestPaidOnLeaseFinancingObligations	0	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	156000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	208000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1787000	usd
CY2023Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1945000	usd
CY2024Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	83000	usd
CY2023Q2	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	20000	usd
CY2024Q1	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	0	usd
CY2023Q2	us-gaap	Sale And Leaseback Transaction Gain Loss Net SaleAndLeasebackTransactionGainLossNet	822000	usd
CY2024Q1	tast	Accrual For Financing Costs AccrualForFinancingCosts	4628000	usd
CY2023Q2	tast	Accrual For Financing Costs AccrualForFinancingCosts	10819000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	25983000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	25739000	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	tast	Business Acquisition Share Conversion Price Per Share BusinessAcquisitionShareConversionPricePerShare	9.55
CY2024Q1	tast	Business Acquisition Termination Fee BusinessAcquisitionTerminationFee	19000000	usd
CY2024Q1	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:7pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Year.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Company uses a 52-53 week fiscal year ending on the Sunday closest to December 31. The three months ended March 31, 2024 and April 2, 2023 each contained thirteen weeks. The 2024 fiscal year will end December 29, 2024 and will contain 52 weeks.</span></div>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:8pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The preparation of the unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant items subject to such estimates include accrued occupancy costs, insurance liabilities, lease accounting matters, the valuation of acquired assets and liabilities, interest rate swap valuation, the valuation of deferred income tax assets and liabilities, and the evaluation for impairment of goodwill, long-lived assets and franchise rights. Actual results could differ from those estimates.</span></div>
CY2024Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	26300000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	5500000	usd
CY2024Q1	tast	Accrued Interest Rate Swap Noncurrent Fair Value AccruedInterestRateSwapNoncurrentFairValue	4900000	usd
CY2023Q4	tast	Accrued Interest Rate Swap Noncurrent Fair Value AccruedInterestRateSwapNoncurrentFairValue	5100000	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	100000	usd
CY2024Q1	tast	Accrued Unearned Income AccruedUnearnedIncome	12477000	usd
CY2023Q4	tast	Accrued Unearned Income AccruedUnearnedIncome	511000	usd
CY2024Q1	tast	Franchise Agreement Number Of Renewal Periods FranchiseAgreementNumberOfRenewalPeriods	1	period
CY2024Q1	tast	Franchise Agreement Term FranchiseAgreementTerm	P20Y
CY2024Q1	tast	Amortizationofintangibleassetsfranchiserights Amortizationofintangibleassetsfranchiserights	3500000	usd
CY2024Q1	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1400000	usd
CY2024Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	700000	usd
CY2023Q2	tast	Impairment And Other Lease Charges ImpairmentAndOtherLeaseCharges	1300000	usd
CY2023Q2	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1200000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	6569000	usd
CY2023Q4	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	4855000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	5546000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	654000	usd
CY2024Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	7405000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	7333000	usd
CY2024Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	17429000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	15767000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	49426000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	29120000	usd
CY2024Q1	tast	Accrual For Occupancy Costs Noncurrent AccrualForOccupancyCostsNoncurrent	1703000	usd
CY2023Q4	tast	Accrual For Occupancy Costs Noncurrent AccrualForOccupancyCostsNoncurrent	1766000	usd
CY2024Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	3732000	usd
CY2023Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	3994000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2970000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3162000	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1236000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1249000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	956000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1140000	usd
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	10597000	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	11311000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P20Y
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	3478000	usd
CY2023Q2	us-gaap	Variable Lease Cost VariableLeaseCost	5471000	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	801000	usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	825000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	156000	usd
CY2023Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	208000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	33332000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	33172000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	9054000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	9752000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	431460000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	433220000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	7108000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	7159000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3770000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4010000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	236000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	263000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	420346000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	421788000	usd
CY2019Q4	tast	First Lien Leverage Ratio FirstLienLeverageRatio	5.75
CY2019Q4	tast	Letters Of Credit Undrawn Maximum LettersOfCreditUndrawnMaximum	12000000	usd
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	11000000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	204000000	usd
CY2021Q2	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.40
CY2024Q1	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	220000000	usd
CY2024Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	1400000	usd
CY2023Q2	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	1100000	usd
CY2024Q1	tast	Accrued Interest Rate Swap Noncurrent Fair Value AccruedInterestRateSwapNoncurrentFairValue	4900000	usd
CY2024Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.055
CY2023Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.058
CY2024Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	213000	usd
CY2023Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-98000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2473000	usd
CY2024Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-125000	usd
CY2023Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1331000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1142000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.179	rate
CY2024Q1	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	700000	usd
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.187
CY2023Q2	us-gaap	Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability	800000	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	61400000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	47300000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42700000	usd
CY2024Q1	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-100000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2000000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1100000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	10300000	usd
CY2024Q1	tast	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Value Expected To Vest In Remainder Of Fiscal Year EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedValueExpectedToVestInRemainderOfFiscalYear	6100000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2734760	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.84
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	645809	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.42
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1028216	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.07
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2352353	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.27
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	7.12
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	925000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.12
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	925000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.12
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2211000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2211000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2211000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	925000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	7.12
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2211000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2211000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2211000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	925000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.12
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2211000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2211000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2211000	usd
CY2024Q1	us-gaap	Share Price SharePrice	9.51
CY2024Q1	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	7600000	usd
CY2024Q1	tast	Guarantor Obligations Payments Made GuarantorObligationsPaymentsMade	0	usd
CY2024Q1	tast	Guarantor Obligations Expected Future Payments GuarantorObligationsExpectedFuturePayments	0	usd
CY2024Q1	tast	Number Of Distributors NumberOfDistributors	3	distributor
CY2024Q1	tast	Estimated Advisory Fees Payable EstimatedAdvisoryFeesPayable	12300000	usd
CY2024Q1	tast	Estimated Advisory Fees Payable Current EstimatedAdvisoryFeesPayableCurrent	2000000	usd
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	100	shares
CY2024Q1	tast	Convertible Preferred Stock Common Shares Issuable Upon Conversion ConvertiblePreferredStockCommonSharesIssuableUponConversion	9414580	shares
CY2024Q1	tast	Board Of Directors Number Of Members BoardOfDirectorsNumberOfMembers	2
CY2024Q1	tast	Franchise Agreement Term FranchiseAgreementTerm	P20Y
CY2024Q1	tast	Franchise Term FranchiseTerm	20	y
CY2024Q1	tast	Monthly Digital Platform Fee MonthlyDigitalPlatformFee	900000	usd
CY2023Q2	tast	Monthly Digital Platform Fee MonthlyDigitalPlatformFee	700000	usd
CY2021Q1	tast	Area Development Agreement Restaurants To Be Opened Built And Operated AreaDevelopmentAgreementRestaurantsToBeOpenedBuiltAndOperated	50	restaurant
CY2021Q1	tast	Area Development Agreement Percentage Of New Restaurants To Be In Kentucky Tennessee And Indiana AreaDevelopmentAgreementPercentageOfNewRestaurantsToBeInKentuckyTennesseeAndIndiana	0.80
CY2021Q3	tast	Area Development Agreement Restaurants To Be Opened Built And Operated AreaDevelopmentAgreementRestaurantsToBeOpenedBuiltAndOperated	4	restaurant
CY2022Q3	tast	Area Development Agreement Restaurants To Be Opened Built And Operated AreaDevelopmentAgreementRestaurantsToBeOpenedBuiltAndOperated	10	restaurant
CY2023Q1	tast	Area Development Agreement Restaurants Completed AreaDevelopmentAgreementRestaurantsCompleted	6	restaurant
CY2023Q3	tast	Area Development Agreement Restaurants To Be Opened Built And Operated AreaDevelopmentAgreementRestaurantsToBeOpenedBuiltAndOperated	12	restaurant
CY2023Q4	tast	Area Development Agreement Restaurants Completed AreaDevelopmentAgreementRestaurantsCompleted	3	restaurant
CY2021Q1	tast	Area Development Agreement Number Of Restaurants To Be Acquired AreaDevelopmentAgreementNumberOfRestaurantsToBeAcquired	500	restaurant
CY2021Q1	tast	Area Development Agreement Number Of States AreaDevelopmentAgreementNumberOfStates	16	state
CY2024Q1	us-gaap	Number Of Restaurants NumberOfRestaurants	227	restaurant
CY2024Q1	tast	Number Of Restaurants Remodeled NumberOfRestaurantsRemodeled	8	restaurant
CY2024Q1	us-gaap	Dividends Payable Amount Per Share DividendsPayableAmountPerShare	0.02
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3664000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2942000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	704000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52325476	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51422010	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3664000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	864000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52325476	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51422010	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11896401	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	9998024	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64221877	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61420034	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2024Q1	us-gaap	Other Expenses OtherExpenses	2000000	usd
CY2024Q1	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	1500000	usd
CY2024Q1	us-gaap	Gain Loss On Condemnation GainLossOnCondemnation	700000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	200000	usd
CY2023Q2	us-gaap	Other Expenses OtherExpenses	1500000	usd
CY2023Q2	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	900000	usd
CY2023Q2	us-gaap	Sales Type And Direct Financing Leases Profit Loss SalesTypeAndDirectFinancingLeasesProfitLoss	800000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	200000	usd

Files In Submission

Name	View Source	Status
0000809248-24-000061-index-headers.html	Edgar Link	pending
0000809248-24-000061-index.html	Edgar Link	pending
0000809248-24-000061.txt	Edgar Link	pending
0000809248-24-000061-xbrl.zip	Edgar Link	pending
debderbyfirstamendmenttoem.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tast-20240331.htm	Edgar Link	pending
tast-20240331.xsd	Edgar Link	pending
tast-ex311_20240331.htm	Edgar Link	pending
tast-ex312_20240331.htm	Edgar Link	pending
tast-ex321_20240331.htm	Edgar Link	pending
tast-ex322_20240331.htm	Edgar Link	pending
tast-20240331_def.xml	Edgar Link	unprocessable
tast-20240331_lab.xml	Edgar Link	unprocessable
tast-20240331_pre.xml	Edgar Link	unprocessable
tast-20240331_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
tast-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

CARROLS RESTAURANT GROUP, INC.

2024 Q2 Form 10-Q Financial Statement

#000080924824000061 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission